Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with the kidney survival time in chronic kidney disease patients

References

• Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
   PubMed Web of Science ®Google Scholar
• Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
   Google Scholar
• Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: A 21st century challenge in global health. Nephron Clin Pract. 2011;118:c269–c277
   PubMedGoogle Scholar
• Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: Improving global outcomes. Kidney Int. 2004;66:1310–1314
   PubMed Web of Science ®Google Scholar
• Yano Y, Fujimoto S, Asahi K, Watanabe T. Prevalence of chronic kidney disease in China. Lancet. 2012;380:213–214; author reply 214–216
   PubMedGoogle Scholar
• Keane WF, Zhang Z, Lyle PA, et al. Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: The RENAAL study. Clin J Am Soc Nephrol. 2006;1:761–767
   PubMed Web of Science ®Google Scholar
• Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004;164:659–663
   PubMed Web of Science ®Google Scholar
• Schrier RW, McFann KK, Johnson AM. Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease. Kidney Int. 2003;63:678–685
   PubMed Web of Science ®Google Scholar
• Lopez-Novoa JM, Martinez-Salgado C, Rodriguez-Pena AB, Lopez-Hernandez FJ. Common pathophysiological mechanisms of chronic kidney disease: Therapeutic perspectives. Pharmacol Ther. 2010;128:61–81
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int. 2002;62:1524–1538
   PubMed Web of Science ®Google Scholar
• Greiber S, Muller B, Daemisch P, Pavenstadt H. Reactive oxygen species alter gene expression in podocytes: Induction of granulocyte macrophage-colony-stimulating factor. J Am Soc Nephrol. 2002;13:86–95
   PubMedGoogle Scholar
• Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 2009;417:1–13
   PubMed Web of Science ®Google Scholar
• Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787–790
   PubMed Web of Science ®Google Scholar
• Lee HC, Yin PH, Lin JC, et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci. 2005;1042:109–122
   PubMed Web of Science ®Google Scholar
• DiMauro S, Schon EA. Mitochondrial DNA mutations in human disease. Am J Med Genet. 2001;106:18–26
   PubMed Web of Science ®Google Scholar
• Beal MF. Mitochondria, free radicals, and neurodegeneration. Curr Opin Neurobiol. 1996;6:661–666
   PubMed Web of Science ®Google Scholar
• Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G. Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science. 1999;286:774–779
   PubMed Web of Science ®Google Scholar
• Mueller EE, Eder W, Ebner S, et al. The mitochondrial T16189C polymorphism is associated with coronary artery disease in Middle European populations. PLoS One. 2011;6:e16455
   PubMed Web of Science ®Google Scholar
• Zhang R, Wang R, Zhang F, et al. Single nucleotide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2010;29:155
   PubMed Web of Science ®Google Scholar
• Guo Z, Yang H, Zhang F, Zhang R, Wang C. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of esophageal squamous cell carcinoma. Oncol Lett. 2012;3:482–484
   PubMed Web of Science ®Google Scholar
• Bai Y, Guo Z, Xu J, et al. Association of sequence polymorphism in the mitochondrial D-loop with chronic kidney disease. Ren Fail. 2014;36(5):781–784
   PubMed Web of Science ®Google Scholar
• Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461–470
   PubMed Web of Science ®Google Scholar
• Stoneking M. Hypervariable sites in the mtDNA control region are mutational hotspots. Am J Hum Genet. 2000;67:1029–1032
   PubMed Web of Science ®Google Scholar
• Takasaki S. Mitochondrial SNPs associated with Japanese centenarians, Alzheimer's patients, and Parkinson's patients. Comput Biol Chem. 2008;32:332–337
   PubMed Web of Science ®Google Scholar
• Vives-Bauza C, Andreu AL, Manfredi G, et al. Sequence analysis of the entire mitochondrial genome in Parkinson's disease. Biochem Biophys Res Commun. 2002;290:1593–1601
   PubMed Web of Science ®Google Scholar
• Bandy B, Davison AJ. Mitochondrial mutations may increase oxidative stress: Implications for carcinogenesis and aging? Free Radic Biol Med. 1990;8:523–539
   PubMed Web of Science ®Google Scholar
• Hervouet E, Simonnet H, Godinot C. Mitochondria and reactive oxygen species in renal cancer. Biochimie. 2007;89:1080–1088
   PubMedGoogle Scholar
• Nagasawa Y, Yamamoto R, Rakugi H, Isaka Y. Cigarette smoking and chronic kidney diseases. Hypertens Res. 2012;35:261–265
   PubMed Web of Science ®Google Scholar
• Daumit GL, Hermann JA, Powe NR. Relation of gender and health insurance to cardiovascular procedure use in persons with progression of chronic renal disease. Med Care. 2000;38:354–365
   PubMedGoogle Scholar
• Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med. 2009;69:342–350
   Google Scholar
• Neugarten J, Golestaneh L. Gender and the prevalence and progression of renal disease. Adv Chronic Kidney Dis. 2013;20:390–395
   PubMedGoogle Scholar
• Chen JB, Yang YH, Lee WC, et al. Sequence-based polymorphisms in the mitochondrial D-loop and potential SNP predictors for chronic dialysis. PLoS One. 2012;7:e41125
   PubMed Web of Science ®Google Scholar
• Zalba G, Fortuno A, Diez J. Oxidative stress and atherosclerosis in early chronic kidney disease. Nephrol Dial Transplant. 2006;21:2686–2690
   PubMed Web of Science ®Google Scholar